Effects on labeling index as a predictor of response to chemotherapy in the 13762 adenocarcinoma

Robert B Livingston, Patti Johnson, Marlene Goormastic, George W. Williams

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A series of 24 experiments was carried out, in which treatment effect was determined in vivo on rats bearing measurable implants, of 13762 adenocarcinoma treated with a variety of chemotherapeutic agents, alone or in combination. In 11 experiments, a reduction in mean tumor are was observed after treatment (response) while 13 showed no such effect (no response). For each experiment, cells from tumor-bearing animals were placed in suspension culture (10 experiments) or in two-layer soft-agar culture (14 experiemnts) after 24 h of exposure to drug-containing plasma or control plasma. Cells were harvested from cultures at 24-h intervals thereafter for determination of the thymidine labeling index in treated versus control populations. The sum of labeling indices in control plasma divided by that in treated plasma was determined to combine the available data over time (overall ratio). Critical values for this ratio were defined, which demonstrated significant depression of the labeling index. Significant labeling index depression occurred in nine of 11 experiments where response in vivo occurred, and in one of 13 in which no response was seen (P=0.0004 by Fisher's exact test). When experiments carried out in soft agar culture or in suspension culture were examined separately, the association of labeling index depression in vitro and response in vivo remained statistically significant. In this model system, labeling index depression by drug-containing plasma is highly predictive of response to therapy.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalCancer Chemotherapy and Pharmacology
Volume10
Issue number1
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Chemotherapy
Labeling
Adenocarcinoma
Drug Therapy
Plasmas
Bearings (structural)
Experiments
Agar
Suspensions
Tumors
Pharmaceutical Preparations
Thymidine
Neoplasms
Therapeutics
Rats
Animals
Association reactions
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Effects on labeling index as a predictor of response to chemotherapy in the 13762 adenocarcinoma. / Livingston, Robert B; Johnson, Patti; Goormastic, Marlene; Williams, George W.

In: Cancer Chemotherapy and Pharmacology, Vol. 10, No. 1, 1982, p. 47-50.

Research output: Contribution to journalArticle

Livingston, Robert B ; Johnson, Patti ; Goormastic, Marlene ; Williams, George W. / Effects on labeling index as a predictor of response to chemotherapy in the 13762 adenocarcinoma. In: Cancer Chemotherapy and Pharmacology. 1982 ; Vol. 10, No. 1. pp. 47-50.
@article{84ddfb09f39249479b0365b3c325e2e5,
title = "Effects on labeling index as a predictor of response to chemotherapy in the 13762 adenocarcinoma",
abstract = "A series of 24 experiments was carried out, in which treatment effect was determined in vivo on rats bearing measurable implants, of 13762 adenocarcinoma treated with a variety of chemotherapeutic agents, alone or in combination. In 11 experiments, a reduction in mean tumor are was observed after treatment (response) while 13 showed no such effect (no response). For each experiment, cells from tumor-bearing animals were placed in suspension culture (10 experiments) or in two-layer soft-agar culture (14 experiemnts) after 24 h of exposure to drug-containing plasma or control plasma. Cells were harvested from cultures at 24-h intervals thereafter for determination of the thymidine labeling index in treated versus control populations. The sum of labeling indices in control plasma divided by that in treated plasma was determined to combine the available data over time (overall ratio). Critical values for this ratio were defined, which demonstrated significant depression of the labeling index. Significant labeling index depression occurred in nine of 11 experiments where response in vivo occurred, and in one of 13 in which no response was seen (P=0.0004 by Fisher's exact test). When experiments carried out in soft agar culture or in suspension culture were examined separately, the association of labeling index depression in vitro and response in vivo remained statistically significant. In this model system, labeling index depression by drug-containing plasma is highly predictive of response to therapy.",
author = "Livingston, {Robert B} and Patti Johnson and Marlene Goormastic and Williams, {George W.}",
year = "1982",
doi = "10.1007/BF00257238",
language = "English (US)",
volume = "10",
pages = "47--50",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Effects on labeling index as a predictor of response to chemotherapy in the 13762 adenocarcinoma

AU - Livingston, Robert B

AU - Johnson, Patti

AU - Goormastic, Marlene

AU - Williams, George W.

PY - 1982

Y1 - 1982

N2 - A series of 24 experiments was carried out, in which treatment effect was determined in vivo on rats bearing measurable implants, of 13762 adenocarcinoma treated with a variety of chemotherapeutic agents, alone or in combination. In 11 experiments, a reduction in mean tumor are was observed after treatment (response) while 13 showed no such effect (no response). For each experiment, cells from tumor-bearing animals were placed in suspension culture (10 experiments) or in two-layer soft-agar culture (14 experiemnts) after 24 h of exposure to drug-containing plasma or control plasma. Cells were harvested from cultures at 24-h intervals thereafter for determination of the thymidine labeling index in treated versus control populations. The sum of labeling indices in control plasma divided by that in treated plasma was determined to combine the available data over time (overall ratio). Critical values for this ratio were defined, which demonstrated significant depression of the labeling index. Significant labeling index depression occurred in nine of 11 experiments where response in vivo occurred, and in one of 13 in which no response was seen (P=0.0004 by Fisher's exact test). When experiments carried out in soft agar culture or in suspension culture were examined separately, the association of labeling index depression in vitro and response in vivo remained statistically significant. In this model system, labeling index depression by drug-containing plasma is highly predictive of response to therapy.

AB - A series of 24 experiments was carried out, in which treatment effect was determined in vivo on rats bearing measurable implants, of 13762 adenocarcinoma treated with a variety of chemotherapeutic agents, alone or in combination. In 11 experiments, a reduction in mean tumor are was observed after treatment (response) while 13 showed no such effect (no response). For each experiment, cells from tumor-bearing animals were placed in suspension culture (10 experiments) or in two-layer soft-agar culture (14 experiemnts) after 24 h of exposure to drug-containing plasma or control plasma. Cells were harvested from cultures at 24-h intervals thereafter for determination of the thymidine labeling index in treated versus control populations. The sum of labeling indices in control plasma divided by that in treated plasma was determined to combine the available data over time (overall ratio). Critical values for this ratio were defined, which demonstrated significant depression of the labeling index. Significant labeling index depression occurred in nine of 11 experiments where response in vivo occurred, and in one of 13 in which no response was seen (P=0.0004 by Fisher's exact test). When experiments carried out in soft agar culture or in suspension culture were examined separately, the association of labeling index depression in vitro and response in vivo remained statistically significant. In this model system, labeling index depression by drug-containing plasma is highly predictive of response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0020353526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020353526&partnerID=8YFLogxK

U2 - 10.1007/BF00257238

DO - 10.1007/BF00257238

M3 - Article

VL - 10

SP - 47

EP - 50

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 1

ER -